Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 301
6
Diseases
13
Unique genes
0.186
Avg. similarity score
Cornelia de lange syndrome
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Cornelia de lange syndrome
De lange syndrome
Congenital muscular hypertrophy-cerebral syndrome
Wiedemann-steiner syndrome
Wilson-turner syndrome
Alazami-yuan syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cornelia de lange syndrome | 5 | 5 | 10 |
| De lange syndrome | 4 | 4 | 6 |
| Congenital muscular hypertrophy-cerebral syndrome | 3 | 3 | 1 |
| Wiedemann-steiner syndrome | 3 | 3 | 5 |
| Wilson-turner syndrome | 2 | 2 | 2 |
| Alazami-yuan syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SMC1A | 4 / 6 | Congenital muscular hypertrophy-cerebral syndrome, Cornelia de lange syndrome, De lange syndrome, Wiedemann-steiner syndrome |
| HDAC8 | 3 / 6 | Cornelia de lange syndrome, De lange syndrome, Wilson-turner syndrome |
| SMC3 | 3 / 6 | Cornelia de lange syndrome, De lange syndrome, Wiedemann-steiner syndrome |
| BRD4 | 2 / 6 | Cornelia de lange syndrome, De lange syndrome |
| KMT2A | 2 / 6 | Cornelia de lange syndrome, Wiedemann-steiner syndrome |
| NIPBL | 2 / 6 | Cornelia de lange syndrome, De lange syndrome |
| RAD21 | 2 / 6 | Cornelia de lange syndrome, De lange syndrome |
| TAF6 | 2 / 6 | Alazami-yuan syndrome, Cornelia de lange syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cohesin Loading onto Chromatin | Reactome | 4 / 10 | 370× | 1.73e-10 | 2.38e-8 ✓ sig. |
| Establishment of Sister Chromatid Cohesion | Reactome | 3 / 11 | 252× | 1.63e-7 | 9.98e-6 ✓ sig. |
| Cell cycle | KEGG | 5 / 158 | 29.2× | 4.37e-7 | 2.38e-5 ✓ sig. |
| Resolution of Sister Chromatid Cohesion | Reactome | 4 / 126 | 29.3× | 7.68e-6 | 2.68e-4 ✓ sig. |
| Separation of Sister Chromatids | Reactome | 4 / 190 | 19.4× | 3.88e-5 | 1.04e-3 ✓ sig. |
| SUMOylation of DNA damage response and repair proteins | Reactome | 3 / 77 | 36.0× | 6.92e-5 | 1.66e-3 ✓ sig. |
| Estrogen-dependent gene expression | Reactome | 3 / 150 | 18.5× | 4.98e-4 | 7.95e-3 ✓ sig. |
| RNA Polymerase II Pre-transcription Events | Reactome | 2 / 84 | 22.0× | 3.59e-3 | 3.49e-2 ✓ sig. |
| Oocyte meiosis | KEGG | 2 / 138 | 13.4× | 9.41e-3 | 6.62e-2 |
| tRNA modification in the nucleus and cytosol | Reactome | 1 / 19 | 48.6× | 2.04e-2 | 1.04e-1 |
| Notch-HLH transcription pathway | Reactome | 1 / 28 | 33.0× | 2.99e-2 | 1.29e-1 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | Reactome | 1 / 38 | 24.3× | 4.04e-2 | 1.53e-1 |
| Basal transcription factors | KEGG | 1 / 44 | 21.0× | 4.66e-2 | 1.65e-1 |
| RNA Polymerase II Promoter Escape | Reactome | 1 / 47 | 19.7× | 4.97e-2 | 1.71e-1 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | Reactome | 1 / 47 | 19.7× | 4.97e-2 | 1.71e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| establishment of mitotic sister chromatid cohesion | GO:0034087 | 4 / 7 | 821× | 4.92e-12 | 1.93e-9 ✓ sig. |
| mitotic sister chromatid cohesion | GO:0007064 | 4 / 16 | 359× | 2.55e-10 | 6.63e-8 ✓ sig. |
| establishment of meiotic sister chromatid cohesion | GO:0034089 | 3 / 4 | 1,078× | 1.05e-9 | 2.34e-7 ✓ sig. |
| sister chromatid cohesion | GO:0007062 | 3 / 20 | 216× | 2.98e-7 | 3.03e-5 ✓ sig. |
| ear morphogenesis | GO:0042471 | 2 / 5 | 575× | 4.46e-6 | 2.74e-4 ✓ sig. |
| replication-born double-strand break repair via sister chromatid exchange | GO:1990414 | 2 / 6 | 479× | 6.69e-6 | 3.78e-4 ✓ sig. |
| chromatin organization | GO:0006325 | 5 / 449 | 16.0× | 8.60e-6 | 4.63e-4 ✓ sig. |
| cognition | GO:0050890 | 3 / 64 | 67.4× | 1.07e-5 | 5.49e-4 ✓ sig. |
| DNA damage response | GO:0006974 | 5 / 577 | 12.5× | 2.89e-5 | 1.19e-3 ✓ sig. |
| chromatin looping | GO:0140588 | 2 / 14 | 205× | 4.05e-5 | 1.54e-3 ✓ sig. |
| chromatin remodeling | GO:0006338 | 4 / 320 | 18.0× | 5.34e-5 | 1.89e-3 ✓ sig. |
| regulation of gene expression | GO:0010468 | 4 / 402 | 14.3× | 1.29e-4 | 3.67e-3 ✓ sig. |
| positive regulation of multicellular organism growth | GO:0040018 | 2 / 34 | 84.6× | 2.48e-4 | 5.88e-3 ✓ sig. |
| mitotic sister chromatid segregation | GO:0000070 | 2 / 38 | 75.7× | 3.10e-4 | 6.87e-3 ✓ sig. |
| transcription initiation-coupled chromatin remodeling | GO:0045815 | 2 / 41 | 70.1× | 3.61e-4 | 7.60e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cornelia de lange syndrome | De lange syndrome | 0.545 | 6 | 1.14e-20 | 2.37e-19 ✓ sig. |
| Cornelia de lange syndrome | Wiedemann-steiner syndrome | 0.231 | 3 | 1.97e-9 | 1.83e-8 ✓ sig. |
| De lange syndrome | Wiedemann-steiner syndrome | 0.200 | 2 | 1.26e-6 | 7.70e-6 ✓ sig. |
| Congenital muscular hypertrophy-cerebral syndrome | Wiedemann-steiner syndrome | 0.167 | 1 | 3.25e-4 | 7.58e-4 ✓ sig. |
| Congenital muscular hypertrophy-cerebral syndrome | De lange syndrome | 0.143 | 1 | 3.90e-4 | 8.52e-4 ✓ sig. |
| Alazami-yuan syndrome | Cornelia de lange syndrome | 0.091 | 1 | 6.49e-4 | 1.22e-3 ✓ sig. |
| Congenital muscular hypertrophy-cerebral syndrome | Cornelia de lange syndrome | 0.091 | 1 | 6.49e-4 | 1.22e-3 ✓ sig. |
| De lange syndrome | Wilson-turner syndrome | 0.125 | 1 | 7.79e-4 | 1.39e-3 ✓ sig. |
| Cornelia de lange syndrome | Wilson-turner syndrome | 0.083 | 1 | 1.30e-3 | 2.04e-3 ✓ sig. |